![]() Analysts Set New Price TargetsĪ number of research firms have issued reports on AMGN. 0.46% of the stock is currently owned by corporate insiders. The disclosure for this sale can be found here. Following the sale, the executive vice president now directly owns 37,333 shares of the company’s stock, valued at $9,027,492.73. The stock was sold at an average price of $241.81, for a total value of $3,264,435.00. Graham sold 13,500 shares of Amgen stock in a transaction on Tuesday, May 10th. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Following the completion of the sale, the director now directly owns 5,501 shares of the company’s stock, valued at $1,375,250. ![]() The stock was sold at an average price of $250.00, for a total transaction of $150,000.00. In related news, Director R Sanders Williams sold 600 shares of Amgen stock in a transaction on Monday, May 23rd. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Following the completion of the sale, the director now owns 5,501 shares in the company, valued at $1,375,250. In other news, Director R Sanders Williams sold 600 shares of the business’s stock in a transaction on Monday, May 23rd. will post 17.37 EPS for the current fiscal year. During the same quarter in the previous year, the company posted $3.70 earnings per share. Amgen had a return on equity of 165.95% and a net margin of 21.75%. The company had revenue of $6.24 billion during the quarter, compared to the consensus estimate of $6.09 billion. The medical research company reported $4.25 earnings per share for the quarter, topping analysts’ consensus estimates of $4.22 by $0.03. Get Amgen alerts:Īmgen ( NASDAQ:AMGN – Get Rating) last released its earnings results on Wednesday, April 27th. 79.01% of the stock is owned by hedge funds and other institutional investors. ![]() Finally, CKW Financial Group acquired a new stake in Amgen in the 1st quarter valued at approximately $31,000. acquired a new stake in Amgen in the 4th quarter valued at approximately $31,000. Industrial Alliance Investment Management Inc. Landmark Wealth Management LLC acquired a new stake in Amgen in the 1st quarter valued at approximately $28,000. ![]() Norwood Financial Corp acquired a new stake in Amgen in the 4th quarter valued at approximately $28,000. Dixon Hughes Goodman Wealth Advisors LLC bought a new position in shares of Amgen in the 4th quarter valued at approximately $26,000. Other hedge funds and other institutional investors also recently made changes to their positions in the company. Congress Park Capital LLC’s holdings in Amgen were worth $1,845,000 as of its most recent SEC filing. The institutional investor owned 7,630 shares of the medical research company’s stock after selling 350 shares during the period. ( NASDAQ:AMGN – Get Rating) by 4.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Congress Park Capital LLC cut its position in shares of Amgen Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |